TrialsgrambetaRCTs are beautiful

ELITE-Symphony

2007

Efficacy Limiting Toxicity Elimination — Symphony Study

In 1,645 kidney-transplant recipients, low-dose tacrolimus with mycophenolate and steroids gave better graft function than the other immunosuppressive regimens.

Result

Primary endpoint: eGFR at 12 months

Low-dose tacrolimus 65.4 mL/min (superior; p<0.001); biopsy-proven rejection 12.3% and graft survival 94.2%.

Original publication
Subtopic
Immunosuppression
Design
Open-label RCT, four arms
Relevance
Practice-defining: a trial the field needs to know.
Source
Ekberg H, et al. N Engl J Med. 2007;357(25):2562-2575.doi 10.1056/NEJMoa067411

Discussion & critique

Established low-dose tacrolimus plus mycophenolate and steroids as the de-novo standard.